UnitedHealth Group Incorporated UNH
NYSE · Healthcare · Medical - Healthcare Plans
$339.85
Close on Fri, 20 Nov 2026 · market value $305B
What the price is betting on
Below its recordAt $340, the price assumes revenue shrinks about 5.8% a year for five years, from $450B to about $348B by FY2030. That is less than what analysts expect for the next two years and less than the company's own last three years.
Revenue growth a year. The price figure comes from a reverse DCF at a 7.7% discount rate.
Track it and Parra checks each report against the path, and tells you when revenue falls behind it.
Own more than UNH? Check up to 5 of your stocks at once, free, no account.
Both sides
Three stories, three values
Bear
$271
Base
$397
Bull
$584
Today $340
- Bear $271. The third-quarter rebound proves a one-off. The Medicare Advantage audit recoveries back to 2018 and the tougher oversight rule become real costs on top of the 2027 plan cuts, and the twelve-month cash flow is flattered by items that do not repeat. Margins stay near FY2025 levels, and with thin liquidity and above-peer leverage the company has little room to absorb the hit, so free cash flow keeps falling faster than the share price already assumes.
- Base $397. Medical costs stay better than a year ago, but part of the gain is given back as Medicare Advantage membership shrinks and the 2027 plan cuts bite. The audit clawback is a real but manageable cost, and the latest twelve-month cash flow includes some items that will not repeat, so cash flow settles between the weak FY2025 level and the recent twelve-month level and drifts a little lower before it stabilises.
- Bull $584. The cost reset sticks and the lower medical care ratio holds in coming quarters. UnitedHealthcare and Optum keep rebuilding profit, Optum Health stays profitable, and the audit clawback and oversight rule prove modest in size, so free cash flow climbs back toward its earlier peak.
AI-written stories, valued by code from the same model.
Checkpoints
The revenue the price needs
- YearNeedsAnalysts expect
- FY2026$443B$455B, on the path
- FY2027$417B$463B, on the path
- FY2028$393B$488B, on the path
- FY2029$370B$511B, on the path
- FY2030$348B$543B, on the path
Each year's revenue at −5.8% growth from $450B in the 12 months to September 2026.
At a glance
Healthcare · Medical - Healthcare Plans · listed on NYSE
- Revenue, FY2025
- $448B
- Growth, 3 years a year
- 7.2%
- Cash margin
- 3.6%
- Net debt
- $50.3B
- Shares, 3-year change
- −4.2%
- Dividend yield
- 2.6%
What other healthcare prices are betting on
Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.